About Us
Marizyme, Inc. is a multi-technology biomedical company dedicated to the development and commercialization of medical technologies that improve patient health outcomes.
Our healthcare innovations address critical market gaps and offer transformative potential to wide range of indications including:
 |
 |
 |
| Coronary Artery Bypass Graft Surgery | Pet Health | Chronic Kidney Disease |
Innovative
Marizyme's products seek to dramatically improve some of the world’s most prevalent and costly healthcare challenges.
Industry Leading
Marizyme seeks to leverage its full suite of biomedical assets to dramatically improve patient outcomes for some of the world’s most prevalent and costly healthcare challenges.
Diverse
With one flagship product and multiple pipeline products and technologies, Marizyme presents opportunity while accounting for risk.
Opportunity
Led by a world-class management team, Marizyme continues to execute on its milestones and deliver both patient and shareholder value.